ExodusPoint Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,491
| Closed | -$623K | – | 1342 |
|
|
2025
Q1 | $623K | Sell |
37,491
-33,295
| -47% | -$553K | 0.01% | 1004 |
|
|
2024
Q4 | $1.3M | Buy |
70,786
+11,885
| +20% | +$218K | 0.01% | 786 |
|
|
2024
Q3 | $906K | Buy |
58,901
+10,816
| +22% | +$166K | 0.01% | 941 |
|
|
2024
Q2 | $781K | Sell |
48,085
-71,407
| -60% | -$1.16M | 0.01% | 976 |
|
|
2024
Q1 | $2.21M | Buy |
+119,492
| New | +$2.21M | 0.02% | 563 |
|
|
2023
Q4 | – | Sell |
-276,829
| Closed | -$5.77M | – | 1329 |
|
|
2023
Q3 | $5.77M | Buy |
+276,829
| New | +$5.77M | 0.06% | 315 |
|
|
2023
Q2 | – | Sell |
-98,890
| Closed | -$1.86M | – | 1708 |
|
|
2023
Q1 | $1.86M | Sell |
98,890
-367,953
| -79% | -$6.92M | 0.02% | 822 |
|
|
2022
Q4 | $7.43M | Buy |
466,843
+405,846
| +665% | +$6.46M | 0.11% | 230 |
|
|
2022
Q3 | $998K | Buy |
60,997
+16,224
| +36% | +$265K | 0.01% | 1072 |
|
|
2022
Q2 | $631K | Sell |
44,773
-28,988
| -39% | -$409K | 0.01% | 1223 |
|
|
2022
Q1 | $1.79M | Buy |
+73,761
| New | +$1.79M | 0.02% | 785 |
|
|
2021
Q3 | – | Sell |
-30,188
| Closed | -$736K | – | 1977 |
|
|
2021
Q2 | $736K | Buy |
30,188
+4,229
| +16% | +$103K | 0.01% | 1095 |
|
|
2021
Q1 | $670K | Sell |
25,959
-29,597
| -53% | -$764K | 0.01% | 1118 |
|
|
2020
Q4 | $2.97M | Buy |
55,556
+40,844
| +278% | +$2.18M | 0.03% | 370 |
|
|
2020
Q3 | $607K | Sell |
14,712
-126,294
| -90% | -$5.21M | 0.01% | 858 |
|
|
2020
Q2 | $6.84M | Buy |
141,006
+132,778
| +1,614% | +$6.44M | 0.18% | 99 |
|
|
2020
Q1 | $348K | Sell |
8,228
-38,553
| -82% | -$1.63M | 0.02% | 565 |
|
|
2019
Q4 | $2M | Buy |
+46,781
| New | +$2M | 0.04% | 297 |
|